Switch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose

By News Health
2 months Ago

(MedPage Today) — Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earlier-generation GLP-1 receptor agonist, an open…

Source link : https://www.medpagetoday.com/endocrinology/diabetes/114983

Author :

Publish date : 2025-04-04 21:35:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Can New Biomarker Help Identify High-Risk DLBCL Patients?

Adjuvant Immunotherapy Ups Survival in dMMR Colon Cancer

Colon Cancer Patients Live Longer With Exercise Prescription

Don't Dismiss the Possibility of Colorectal Cancer in Young Adult Patients

Which Class of ER Degrader Is Better?

Perioperative Durvalumab Plus FLOT Boosts EFS in Resectable Gastric/GEJ Cancer